Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial

Early intervention in COVID-19 patients with sulodexide reduced hospital admissions and oxygen support requirements, although with no significant effect on mortality.
This has beneficial implications in the patient wellbeing, Making sulodexide a favourable medication until an effective vaccine or an antiviral becomes available